Administration of adjuvant chemotherapy for stage II–III colon cancer patients: An European population-based study

The advantage of adjuvant chemotherapy (ACT) for treating Stage III colon cancer patients is well established and widely accepted. However, many patients with Stage III colon cancer do not receive ACT. Moreover, there are controversies around the effectiveness of ACT for Stage II patients. We invest...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Cancer
Main Authors: Babaei, Masoud, Balavarca, Yesilda, Jansen, Lina, Lemmens, Valery, van Erning, Felice N., van Eycken, Liesbet, Vaes, Evelien, Sjövall, Annika, Glimelius, Bengt, Ulrich, Cornelia M., Schrotz-King, Petra, Brenner, Hermann
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6002808/
https://ncbi.nlm.nih.gov/pubmed/29159866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31168
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares